Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novoron Bioscience

Novoron Bioscience
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
4 INVESTORS
Description

Developer of therapeutics designed to treat central nervous system from multiple sclerosis. The company's therapeutics includes treatment for spinal cord injury and glaucoma which will protect the neurons from further damage and maintain function, as well as promote regeneration of the brain and spinal cord, enabling patients to treat and restore natural healing of damaged nerves.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 7770 Regents Road 113319
  • Suite 113319
  • San Diego, CA 92122
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novoron Bioscience’s full profile, request a free trial.

Novoron Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 02-Mar-2018 Completed Startup
5. Angel (individual) Completed Pre-Clinical Trials
4. Accelerator/Incubator 13-Sep-2016 Completed Pre-Clinical Trials
3. Grant 22-Dec-2015 00000 Completed Pre-Clinical Trials
2. Accelerator/Incubator 22-Sep-2014 Completed Pre-Clinical Trials
1. Grant 01-Jan-2014 $595K Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Novoron Bioscience Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Backstage Capital Venture Capital Minority 000 0000 000000 0
RESI on MaRS Innovation Other 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Novoron Bioscience Executive Team (4)

Name Title Board
Seat
Contact
Info
Travis Stiles Ph.D Co-Founder, President & Chief Executive Officer
Shawn Gahr Co-Founder & Co-Corporate Development Officer
Taylor Bright Ph.D Co-Founder & Co-Corporate Development Officer

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »